SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017318
Filing Date
2019-05-08
Accepted
2019-05-08 17:08:47
Documents
63
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sndx-10q_20190331.htm 10-Q 1670230
2 EX-10.1 sndx-ex101_122.htm EX-10.1 23352
3 EX-31.1 sndx-ex311_6.htm EX-31.1 10278
4 EX-31.2 sndx-ex312_8.htm EX-31.2 10731
5 EX-32.1 sndx-ex321_7.htm EX-32.1 11873
  Complete submission text file 0001564590-19-017318.txt   6270061

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sndx-20190331.xml EX-101.INS 1434492
7 XBRL TAXONOMY EXTENSION SCHEMA sndx-20190331.xsd EX-101.SCH 50543
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sndx-20190331_cal.xml EX-101.CAL 42736
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sndx-20190331_def.xml EX-101.DEF 154361
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20190331_lab.xml EX-101.LAB 349675
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20190331_pre.xml EX-101.PRE 259429
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 19807615
SIC: 2834 Pharmaceutical Preparations